Search research articles
Contact Us
Filters
Showing results (301-310 of 403) with videos related to
Page
of 41
Sort By:
Journal of Drugs in Dermatology : JDD
|
September 5, 2025
Glucagon-Like Peptide-1 Receptor Agonists Reduce Surgeries and Hospitalizations in Hidradenitis Suppurativa: A Multicenter TriNetX Cohort Study
Neal Gupta, Kayla Zafar, Paras Patel, et al.
European Heart Journal
|
October 3, 2003
Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry
Marc Cohen, Philip Urban, Jan T Christenson, et al.
American Heart Journal
|
July 1, 2008
Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome
Steve Leung, Dianne Gallup, Kenneth W Mahaffey, et al.
American Heart Journal
|
March 31, 2015
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)
C Michael Gibson, Roxana Mehran, Christoph Bode, et al.
The Journal of Cardiovascular Nursing
|
August 8, 2025
Depression and Physical Activity Post Cardiac Surgery: 18 Months of Follow-up
Marc Cohen, Liza Grosman-Rimon, Noa Caspi-Avissar, et al.
American Journal of Surgery
|
October 12, 2004
Association of breast cancer with papillary lesions identified at percutaneous image-guided breast biopsy
Leah S Gendler, Sheldon M Feldman, Ronald Balassanian, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 1, 2010
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial
Marc Cohen, Glenn N Levine, Karen S Pieper, et al.
Pituitary
|
September 9, 2024
Sleep disruption in patients with active and treated endogenous Cushing's syndrome
Eliza B Geer, Isabelle Grillo, Qing Li, et al.
Journal of Thrombosis and Thrombolysis
|
February 11, 2012
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin
Michael P Thomas, Kenneth W Mahaffey, Karen Chiswell, et al.
Head & Neck
|
July 24, 2024
Outcomes of SMARCB1-deficient sinonasal carcinoma: Largest single-center cross-sectional study
Robbie Woods, Daniel Scholfield, Lucas Axiotakis, et al.
Page
of 41
Search research articles
Search
Showing results (301-310 of 403) with videos related to
Sort By:
Page
of 41
Journal of Drugs in Dermatology : JDD
|
September 5, 2025
Glucagon-Like Peptide-1 Receptor Agonists Reduce Surgeries and Hospitalizations in Hidradenitis Suppurativa: A Multicenter TriNetX Cohort Study
Neal Gupta, Kayla Zafar, Paras Patel, et al.
European Heart Journal
|
October 3, 2003
Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry
Marc Cohen, Philip Urban, Jan T Christenson, et al.
American Heart Journal
|
July 1, 2008
Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome
Steve Leung, Dianne Gallup, Kenneth W Mahaffey, et al.
American Heart Journal
|
March 31, 2015
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)
C Michael Gibson, Roxana Mehran, Christoph Bode, et al.
The Journal of Cardiovascular Nursing
|
August 8, 2025
Depression and Physical Activity Post Cardiac Surgery: 18 Months of Follow-up
Marc Cohen, Liza Grosman-Rimon, Noa Caspi-Avissar, et al.
American Journal of Surgery
|
October 12, 2004
Association of breast cancer with papillary lesions identified at percutaneous image-guided breast biopsy
Leah S Gendler, Sheldon M Feldman, Ronald Balassanian, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 1, 2010
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial
Marc Cohen, Glenn N Levine, Karen S Pieper, et al.
Pituitary
|
September 9, 2024
Sleep disruption in patients with active and treated endogenous Cushing's syndrome
Eliza B Geer, Isabelle Grillo, Qing Li, et al.
Journal of Thrombosis and Thrombolysis
|
February 11, 2012
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin
Michael P Thomas, Kenneth W Mahaffey, Karen Chiswell, et al.
Head & Neck
|
July 24, 2024
Outcomes of SMARCB1-deficient sinonasal carcinoma: Largest single-center cross-sectional study
Robbie Woods, Daniel Scholfield, Lucas Axiotakis, et al.
Page
of 41